ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,301.98
1.05%
US Tech 100
18,086.80
1.40%
다우존스 지수
39,845.45
0.73%
Bitcoin
65,042.41
5.68%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU
  6. Neovacs (ALNEV)

  7. Neovacs (ALNEV) 뉴스

ALNEV

Neovacs (ALNEV)

Neovacs
일자:
정렬 기준:
 검색 관련기사 보기:EU:ALNEV
일자시간출처헤드라인심볼기업
2019/12/0701:45GlobeNewswire Inc.OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGSEU:ALNEVNeovacs
2019/12/0701:45GlobeNewswire Inc.APPEL D’OFFRES EN VUE D’UN PLAN DE CONTINUATION OU DE CESSION DANS LE CADRE D’UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE...EU:ALNEVNeovacs
2019/11/2803:00GlobeNewswire Inc.NEOVACS :EU:ALNEVNeovacs
2019/11/1402:00GlobeNewswire Inc.NEOVACS REQUESTS A REORGANIZATION PROCEEDINGS OF THE COMPANYEU:ALNEVNeovacs
2019/11/1402:00GlobeNewswire Inc.NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIREEU:ALNEVNeovacs
2019/11/0904:05GlobeNewswire Inc.POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSEEU:ALNEVNeovacs
2019/10/3101:45GlobeNewswire Inc.MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019EU:ALNEVNeovacs
2019/10/0304:31GlobeNewswire Inc.NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTSEU:ALNEVNeovacs
2019/10/0304:31GlobeNewswire Inc.NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019EU:ALNEVNeovacs
2019/09/3015:30GlobeNewswire Inc.NÉOVACS ANNONCE LA NOMINATION DE VINCENT SERRA EN QUALITÉ DE DIRECTEUR GÉNÉRALEU:ALNEVNeovacs
2019/09/3015:30GlobeNewswire Inc.NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICEREU:ALNEVNeovacs
2019/09/1000:45GlobeNewswire Inc.Neovacs : 2019 Financial CalendarEU:ALNEVNeovacs
2019/09/1000:45GlobeNewswire Inc.Néovacs : Agenda financier 2019EU:ALNEVNeovacs
2019/07/0914:30GlobeNewswire Inc.NEOVACS ANNOUNCES THAT THE POSITIVE RESULTS OF ITS PROOF OF CONCEPT IN ALLERGIES WITH IL-4 / IL-13 KINOID HAVE TRIGGERED THE ...EU:ALNEVNeovacs
2019/07/0914:30GlobeNewswire Inc.NÉOVACS REÇOIT LE PREMIER VERSEMENT DE LA SUBVENTION ANR SUITE À LA PRÉSENTATION DES RÉSULTATS POSITIFS DE SA PREUVE DE ...EU:ALNEVNeovacs
2019/06/2714:30GlobeNewswire Inc.NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOREU:ALNEVNeovacs
2019/06/2714:30GlobeNewswire Inc.NÉOVACS ANNONCE LA NOMINATION DU Dr. VIRGINIA PASCUAL EN TANT QUE CONSEILLÈRE MÉDICALE ET SCIENTIFIQUEEU:ALNEVNeovacs
2019/06/0514:30GlobeNewswire Inc.Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat type 1 diabetes - American Diabetes Association's...EU:ALNEVNeovacs
2019/06/0514:30GlobeNewswire Inc.Néovacs présente les résultats précliniques de l'IFNalpha Kinoïde pour le traitement du diabète de type 1 - 79ème conf...EU:ALNEVNeovacs
2019/06/0400:56GlobeNewswire Inc.Néovacs annonce avoir réuni son Assemblée Générale Mixte sur seconde convocation le mercredi 29 mai 2019EU:ALNEVNeovacs
2019/05/2314:30GlobeNewswire Inc.NÉOVACS PROCÈDE AUX TIRAGES DE LA SECONDE TRANCHE PRÉVUE PAR SON PROGRAMME DE FINANCEMENT ET D’UNE TRANCHE ADDITIONNELLE...EU:ALNEVNeovacs
2019/05/1614:30GlobeNewswire Inc.Neovacs to present the pre-clinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid to treat allergic Asthma...EU:ALNEVNeovacs
2019/05/1614:30GlobeNewswire Inc.Néovacs présente les résultats précliniques de son candidat vaccin thérapeutique IL-4 / IL-13 Kinoïde pour le traitemen...EU:ALNEVNeovacs
2019/05/0100:45GlobeNewswire Inc.Néovacs : mise à disposition du rapport financier annuel 2018 et du rapport sur le gouvernement d'entrepriseEU:ALNEVNeovacs
2019/04/0914:30GlobeNewswire Inc.Neovacs announces the full results of its Phase IIb Clinical study of IFNalpha Kinoid in lupus - 13th International Lupus Con...EU:ALNEVNeovacs
2019/04/0914:30GlobeNewswire Inc.Néovacs annonce les résultats complets de son étude clinique de phase IIb avec l'IFNalpha Kinoïde dans le lupus - 13ème ...EU:ALNEVNeovacs
2019/04/0601:00GlobeNewswire Inc.Agenda financier 2019EU:ALNEVNeovacs
2019/04/0601:00GlobeNewswire Inc.2019 Financial CalendarEU:ALNEVNeovacs
2019/04/0114:30GlobeNewswire Inc.Néovacs annonce un accord avec Biosyn GmbH afin de diversifier son approvisionnement en Keyhole Limpet Hemocyanin (KLH)EU:ALNEVNeovacs
2019/04/0114:30GlobeNewswire Inc.Neovacs announces an agreement with Biosyn GmbH to diversify its supply of Keyhole Limpet Hemocyanin (KLH)EU:ALNEVNeovacs
 검색 관련기사 보기:EU:ALNEV

최근 히스토리

PM
XAUUSD
Gold vs US Dollar
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
NYSE
CVX
Chevron
USOTC
BNPQY
BNP Paribas (QX)
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
FX
USDEUR
US Dollar vs Euro
CCOM
US30
US 30
FX
USDGBP
US Dollar vs Sterling
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유